CERT Insider Trading
Certara, Inc. | Services-Prepackaged Software
Comprehensive Trading Performance Summary
The investment history of corporate insiders at Certara, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Services-Prepackaged Software sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2025-11-13 00:44 | 2025-11-11 | Feehery William F | Director, Officer - CHIEF EXECUTIVE OFFICER | BUY | $8.30 | 24,096 | $200,000 | 2,360,769 | +1.0% |
| 2025-09-11 23:47 | 2025-09-09 | Pedersen Leif E | Officer - PRESIDENT, CHIEF COMMERCAL OFF | SELL | $10.92 | 51,224 | $559,366 | 73,979 | -40.9% |
| 2024-10-08 23:17 | 2024-10-07 | SMITH PATRICK F | Officer - PRESIDENT, DRUG DEV SOLUTIONS | SELL | $11.03 | 5,409 | $59,661 | 50,091 | -9.7% |
| 2024-09-11 00:01 | 2024-09-09 | Pedersen Leif E | Officer - PRESIDENT, CHIEF COMMERCAL OFF | SELL | $11.29 | 51,224 | $578,319 | 99,704 | -33.9% |
| 2024-04-04 23:45 | 2024-04-02 | SMITH PATRICK F | Officer - PRESIDENT, DRUG DEV SOLUTIONS | SELL | $16.85 | 14,427 | $243,161 | 50,091 | -22.4% |
| 2024-04-04 00:08 | 2024-04-01 | Traynor Richard M. | Officer - SVP AND GENERAL COUNSEL | OPT+S | $18.00 | 3,000 | $54,000 | 173,524 | 0.0% |
| 2024-03-06 00:45 | 2024-03-04 | Traynor Richard M. | Officer - SVP AND GENERAL COUNSEL | SELL | $18.28 | 3,000 | $54,840 | 162,368 | -1.8% |
| 2024-02-22 00:40 | 2024-02-20 | SMITH PATRICK F | Officer - PRESIDENT, DRUG DEV SOLUTIONS | SELL | $18.00 | 5,000 | $90,000 | 54,975 | -8.3% |
| 2024-02-15 00:33 | 2024-02-12 | Traynor Richard M. | Officer - SVP AND GENERAL COUNSEL | SELL | $18.00 | 6,000 | $108,000 | 165,368 | -3.5% |
| 2023-12-28 02:36 | 2023-12-26 | Traynor Richard M. | Officer - SVP AND GENERAL COUNSEL | SELL | $18.00 | 6,000 | $108,000 | 171,368 | -3.4% |
| 2023-09-12 23:26 | 2023-09-11 | Pedersen Leif E | Officer - PRESIDENT, CHIEF COMMERCAL OFF | SELL | $14.60 | 51,224 | $747,870 | 128,883 | -28.4% |
| 2023-08-23 23:38 | 2023-08-21 | BROSHY ERAN | Director | BUY | $15.81 | 5,000 | $79,058 | 14,360 | +53.4% |
| 2023-06-06 23:56 | 2023-06-05 | SMITH PATRICK F | Officer - PRESIDENT, INTEGRATED DRUG DEV | SELL | $21.55 | 19,104 | $411,691 | 59,975 | -24.2% |
| 2023-05-15 23:41 | 2023-05-11 | Traynor Richard M. | Officer - SVP AND GENERAL COUNSEL | SELL | $20.82 | 5,000 | $104,100 | 177,368 | -2.7% |
| 2023-04-18 00:07 | 2023-04-14 | Traynor Richard M. | Officer - SVP AND GENERAL COUNSEL | SELL | $23.66 | 5,000 | $118,300 | 182,368 | -2.7% |
| 2023-03-08 00:35 | 2023-03-06 | Traynor Richard M. | Officer - SVP AND GENERAL COUNSEL | SELL | $21.45 | 10,000 | $214,500 | 184,564 | -5.1% |
| 2023-02-04 00:40 | 2023-02-02 | Traynor Richard M. | Officer - SVP AND GENERAL COUNSEL | SELL | $20.00 | 15,000 | $300,000 | 194,564 | -7.2% |
| 2022-12-13 00:16 | 2022-12-08 | EQT Avatar Parent L.P. | 10% owner | SELL | $15.00 | 29,954,521 | $449,317,815 | 0 | -100.0% |
| 2022-11-24 00:54 | 2022-11-22 | Pedersen Leif E | Officer - PRESIDENT, SOFTWARE | SELL | $15.55 | 51,223 | $796,518 | 175,500 | -22.6% |
| 2022-11-17 00:27 | 2022-11-14 | SLAINE MASON P | Director | SELL | $15.57 | 250,000 | $3,891,250 | 660,322 | -27.5% |
| 2022-11-16 00:50 | 2022-11-14 | WALSH MATTHEW M | Director | SELL | $14.74 | 12,059 | $177,750 | 167,901 | -6.7% |
| 2022-11-15 00:33 | 2022-11-09 | SMITH PATRICK F | Officer - PRESIDENT, INTEGRATED DRUG DEV | SELL | $13.48 | 2,387 | $32,177 | 74,859 | -3.1% |
| 2022-08-23 15:58 | 2022-08-19 | McLean Stephen M. | Director | BUY | $16.32 | 20,000 | $326,400 | 42,000 | +90.9% |
| 2022-08-19 00:17 | 2022-08-17 | Schemick Michael Andrew | Officer - CHIEF FINANCIAL OFFICER | BUY | $16.64 | 25,000 | $416,000 | 517,870 | +5.1% |
| 2022-08-19 00:12 | 2022-08-16 | SMITH PATRICK F | Officer - PRESIDENT, INTEGRATED DRUG DEV | SELL | $17.71 | 10,000 | $177,100 | 78,490 | -11.3% |
| 2022-08-18 00:01 | 2022-08-16 | EQT Avatar Parent L.P. | 10% owner | SELL | $17.38 | 6,004,418 | $104,356,785 | 29,954,521 | -16.7% |
| 2022-08-18 00:00 | 2022-08-16 | SLAINE MASON P | Director | SELL | $17.38 | 182,475 | $3,171,416 | 910,322 | -16.7% |
| 2022-06-09 23:44 | 2022-06-08 | SMITH PATRICK F | Officer - PRESIDENT, INTEGRATED DRUG DEV | SELL | $19.16 | 10,000 | $191,600 | 88,490 | -10.2% |
| 2022-06-03 23:29 | 2022-06-02 | SLAINE MASON P | Director | SELL | $19.56 | 250,000 | $4,890,000 | 1,092,797 | -18.6% |
| 2022-06-02 01:34 | 2022-05-31 | EQT Avatar Parent L.P. | 10% owner | SELL | $19.00 | 1,500,000 | $28,500,000 | 35,958,939 | -4.0% |
| 2022-04-05 23:26 | 2022-04-04 | SMITH PATRICK F | Officer - PRESIDENT, INTEGRATED DRUG DEV | SELL | $22.29 | 3,352 | $74,716 | 98,490 | -3.3% |
| 2022-03-18 23:39 | 2022-03-16 | Traynor Richard M. | Officer - SVP AND GENERAL COUNSEL | SELL | $20.00 | 3,000 | $60,000 | 211,287 | -1.4% |
| 2022-03-18 23:35 | 2022-03-16 | SLAINE MASON P | Director | SELL | $20.21 | 250,000 | $5,052,500 | 1,342,797 | -15.7% |
| 2022-03-17 23:38 | 2022-03-16 | Feehery William F | Director, Officer - CHIEF EXECUTIVE OFFICER | SELL | $20.17 | 62,485 | $1,260,322 | 2,178,051 | -2.8% |
| 2022-03-14 23:31 | 2022-03-11 | Feehery William F | Director, Officer - CHIEF EXECUTIVE OFFICER | SELL | $20.29 | 27,515 | $558,279 | 2,240,536 | -1.2% |
| 2022-02-23 00:54 | 2022-02-18 | Feehery William F | Director, Officer - CHIEF EXECUTIVE OFFICER | SELL | $23.35 | 75,000 | $1,751,168 | 2,268,051 | -3.2% |
| 2022-02-22 16:17 | 2022-02-17 | Feehery William F | Director, Officer - CHIEF EXECUTIVE OFFICER | SELL | $24.32 | 90,000 | $2,188,602 | 2,343,051 | -3.7% |
| 2022-02-03 00:45 | 2022-02-01 | SLAINE MASON P | Director | SELL | $26.61 | 50,000 | $1,330,495 | 1,592,797 | -3.0% |
| 2022-01-28 00:49 | 2022-01-26 | Traynor Richard M. | Officer - SVP AND GENERAL COUNSEL | SELL | $26.01 | 3,000 | $78,030 | 214,287 | -1.4% |
| 2022-01-28 00:46 | 2022-01-26 | Feehery William F | Director, Officer - CHIEF EXECUTIVE OFFICER | SELL | $25.37 | 75,000 | $1,902,638 | 2,433,051 | -3.0% |
| 2022-01-22 01:48 | 2022-01-20 | Edge Justin | Officer - PRES., REGULATORY & ACCESS | SELL | $27.50 | 5,000 | $137,500 | 397,090 | -1.2% |
| 2022-01-20 16:02 | 2022-01-18 | Traynor Richard M. | Officer - SVP AND GENERAL COUNSEL | SELL | $27.44 | 5,000 | $137,200 | 217,287 | -2.2% |
| 2022-01-05 00:43 | 2022-01-03 | SLAINE MASON P | Director | SELL | $28.63 | 50,000 | $1,431,500 | 1,642,797 | -3.0% |
| 2021-12-29 02:23 | 2021-12-27 | Traynor Richard M. | Officer - SVP AND GENERAL COUNSEL | SELL | $29.30 | 3,000 | $87,900 | 222,287 | -1.3% |
| 2021-12-28 00:43 | 2021-12-23 | CASHMAN JAMES E III | Director | SELL | $29.20 | 25,111 | $733,241 | 438,782 | -5.4% |
| 2021-12-24 00:15 | 2021-12-22 | Feehery William F | Director, Officer - CHIEF EXECUTIVE OFFICER | SELL | $28.58 | 75,000 | $2,143,500 | 2,508,051 | -2.9% |
| 2021-12-24 00:16 | 2021-12-22 | CASHMAN JAMES E III | Director | SELL | $29.00 | 19,889 | $576,781 | 463,893 | -4.1% |
| 2021-12-22 00:57 | 2021-12-20 | Choe Jieun W. | Officer - CHIEF STRATEGY & MARKETING | SELL | $28.00 | 7,500 | $210,000 | 250,491 | -2.9% |
| 2021-12-21 04:09 | 2021-12-17 | Choe Jieun W. | Officer - CHIEF STRATEGY & MARKETING | SELL | $26.13 | 5,000 | $130,650 | 257,991 | -1.9% |
| 2021-12-15 00:27 | 2021-12-13 | SLAINE MASON P | Director | SELL | $28.05 | 50,000 | $1,402,550 | 1,692,797 | -2.9% |
How to Interpret $CERT Trades
Not every insider transaction in Certara, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $CERT shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for CERT
Insider activity data for Certara, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $CERT, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.